Tomudex

Tomudex (raltitrexed) is an antimetabolite chemotherapy medication used for cancer treatment. This intravenous therapy targets rapidly dividing cells, commonly prescribed for colorectal cancer. It belongs to the folate antimetabolite class and requires medical supervision during administration.

Tomudex is primarily used in the treatment of colorectal cancer, helping to slow or stop the growth of cancer cells. It may also be prescribed for other cancers where antimetabolite therapy is appropriate. Patients often receive this medication as part of a broader chemotherapy regimen under the guidance of an oncologist.

As with many chemotherapy drugs, Tomudex may cause side effects such as fatigue, nausea, or changes in blood cell counts. Some patients report mild gastrointestinal discomfort or skin sensitivity during treatment. These effects vary by individual and are typically monitored by healthcare providers.

Tomudex should only be handled and administered by healthcare professionals in a clinical setting. Patients must disclose all medications and health conditions to their doctor before starting treatment. Regular blood tests are usually required to monitor for potential complications.

Tomudex may interact with other folate-based medications or drugs that affect liver enzymes. Alcohol and certain supplements could influence its effects or side effects. Patients should inform their doctor about all prescription, over-the-counter, and herbal products they are using.